论文部分内容阅读
目的研究依达拉奉在老年难治性癫痫中应用价值。方法选择2007年4月-2011年4月我院收治的老年难治性癫痫患者87例为研究对象。按照随机数字表法分两组,观察组(依达拉奉治疗组)43例,对照组(普通治疗组)44例,比较治疗效果及药物不良反应发生率。结果观察组显效率为53.5%,明显高于对照组,P<0.05;不良反应发生率为11.6%,差异不明显,P>0.05。结论依达拉奉治疗老年难治性癫痫临床疗效良好,药物不良反应低,适合应用。
Objective To study the application of edaravone in elderly patients with refractory epilepsy. Methods 87 cases of elderly refractory epilepsy admitted in our hospital from April 2007 to April 2011 were selected as the research object. According to the random number table divided into two groups, the observation group (edaravone treatment group) 43 cases, the control group (general treatment group) 44 cases, the treatment effect and the incidence of adverse drug reactions. Results The effective rate of the observation group was 53.5%, which was significantly higher than that of the control group (P <0.05). The incidence of adverse reactions was 11.6%, with no significant difference (P> 0.05). Conclusion Edaravone is effective in the treatment of senile intractable epilepsy and has low adverse drug reaction.